Gapping down
In reaction to earnings/guidance:
- RCM -21.7%, TRIP -21.2%, QTWO -18.5%, TTWO -17.7%, LYFT -16.9%, NSTG -15.4%, SKIN -11.6%, FIVN -11.4%, LITE -10.5%, AHCO -9.8%, VECO -9.7%, CLVT -9.6%, FLGT -9.3%, DOCN -8.8%, PRGO -7.1%, SSRM -7%, PACB -6.1%, RPRX -6%, FGEN -5.2% (also announces royalty monetization financing with NovaQuest), DBD -5.2%, SSP -4.3%, LGND -3%, NEO -2.8%, UIS -2.3% (also to delay 10-Q filing), SWAV -1.4%, BRKR -1.4%, BNFT -1.3%, TSVT -1.3% (also files $400 mln mixed securities shelf offering), MWA -1.2%, DHT -1.2%, ICUI -1.1%, RETA -1.1%, INSW -1%
Other news:
- ATHX -45.6% (commences common stock offering)
- MRNS -15.3% (prices $60 mln offering consisting of common stock and warrants)
- ROIV -9.8% (prices primary and secondary public offering of 30 mln common shares at $5/share)
- VZLA -9.4% (bought deal financing of 13.8 mln shares at $1.45 per unit)
- BRMK -8% (CEO resigns; names new CFO)
- MDT -5.5% (SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits)
- ABC -4.6% (Walgreens Boots Alliance (WBA) announces offering of 10 million shares of AmerisourceBergen Corporation)
- ARCC -3.6% (prices offering of 8.0 mln shares of common stock)
- LXU -2.8% (prices offering of 14.35 mln shares of common stock at $13.50 per share; co repurchases 3.5 mln shares)
- ENSG -2.2% (ENSG to acquire 20 skilled nursing operations from SBRA)
- IRTC -1.2% (issues results of four studies)
Analyst comments:
- BNFT -1.3% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)